FDA.reportPublic FDA data

cyclosporine 0.05 % Ophthalmic Suspension

RxCUI
351291
RxNorm name
cyclosporine 0.05 % Ophthalmic Suspension
Display name
cyclosporine 0.05 % Ophthalmic Suspension
Full name
cyclosporine 0.05 % Ophthalmic Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Restasis MultiDoseCYCLOSPORINEAllergan, Inc.7224d810-bb96-4682-a942-3355e6e8061a2025-08-21Warnings, Adverse reactionsExact identifier
rxcui: 351291

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7224d810-bb96-4682-a942-3355e6e8061acycloSPORINE 0.05 % Ophthalmic Emulsion [PSN] · cyclosporine 0.5 MG/ML Ophthalmic Suspension [SCD] · cyclosporine 0.05 % Ophthalmic Emulsion [SY] · cyclosporine 0.05 % Ophthalmic Suspension [SY]415These highlights do not include all the information needed to use RESTASIS MULTIDOSE safely and effectively. See full prescribing information for RESTASIS MULTIDOSE . RESTASIS MULTIDOSE ® ( cyclosporine ophthalmic emulsion ) 0.05% , f or topical ophthalmic use Initial U.S. Approval: 198320250821